Aim: To review the various pharmacological approaches currently proposed for the
treatment of hypertension. Results: With the evolution of pharmacological treatment of …

Abstract The 2009 Reappraisal of European guidelines on hypertension management
underlined the need for combination therapy in the vast majority of hypertensive patients. A …

Arterial hypertension is the most important modifiable cardiovascular risk factor leading to
death in general population. Optimal treatment strategies are continuously being debated …

Fixed-dose triple drug combinations represent one of the latest innovations of
pharmacotherapy for hypertension (HT). They combine a traditional renin-angiotensin …

Importance of the field: Hypertension is the most common preventable cause of
cardiovascular morbidity and mortality. Despite the availability of a multitude of …

Current hypertension treatment guidelines recommend a goal of< 140/90mmHg for
population with uncomplicated hypertension and goals are even lower (< 130/80mmHg) for …

A wide selection of antihypertensive drugs are currently available for managing
hypertension, with distinct advantages and disadvantages in selected patient populations …

Society of Hypertension2 guidelines for the management of hypertension proposed that
initial combination therapy with 2 antihypertensive agents in a single-pill combination (SPC) …

Myocardial infarction, stroke, and congestive heart failure are the leading causes of death
and disability in developed countries. Hypertension is one of the most important risk factors …

Cardiovascular diseases are the leading cause of morbility and mortality worldwide. The
main risk factor that contributes to the development of these cardiovascular diseases is …